Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Humira in Japanese patients with moderate to severe chronic plaque psoriasis
NCT00338754Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Nov 2005
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of Trudexa in plaque psoriasis, sponsored by Abbott Laboratories. Started Nov 2005; status: completed.
02
Drugs
Trudexa
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00338754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00338754.